ERBB2 and breast carcinoma: With the advent of gene expression profiling over the last 15 years, breast cancers have been classified into luminal A, luminal B, human epidermal growth factor receptor 2 (HER2 or ERBB2)-enriched, basal-like, and claudin-low categories (Liu & Wang, 2015; Prat et al., 2015).